Table 1 Clinical characteristics of the patients with sarcoidosis.

From: Imbalance in B cell and T Follicular Helper Cell Subsets in Pulmonary Sarcoidosis

Characteristics

Pulmonary sarcoidosis, n (%) (n = 37)

CI 95%

Complaints

Clinical manifestations, n (%)

31 (83.8)

0.6848–0.9273

Weakness, n (%)

22 (59.4)

0.4346–0.7368

Cough, n (%)

20 (54.0)

0.3838–0.6897

Chronic fatigue, n (%)

20 (54.0)

0.3838–0.6897

Dyspnea, n (%)

12 (32.4)

0.1955–0.4862

Weight loss, n (%)

8 (21.6)

0.1114–0.3744

Arthralgia, n (%)

8 (21.6)

0.1114–0.3744

Myalgia, n (%)

6 (16.2)

0.0727–0.3152

Sweating, n (%)

2 (5.4)

0.0057–0.1863

Fever, n (%)

11 (2.9)

0.1737–0.4590

X-ray findings

Enlarged lymph nodes

37 (100.0)

0.8880–1.0000

Foci in the lungs, n (%)

34 (91.9)

0.7797–0.9794

Ground-glass opacity, n (%)

7 (18.9)

0.0917–0.3451

Infiltration, n (%)

5 (13.5)

0.0544–0.2845

Fibrosis, n (%)

3 (8.1)

0.0206–0.2203

Medical history

Smoking, n (%)

16 (43.2)

0.2866–0.5910

Family history of autoimmune diseases, n (%)

3 (8.1)

0.0206–0.2203

Allergy, n (%)

16 (4.3)

0.2866–0.5910

Tests for tuberculosis infection

TB.T-SPOT test (positive)

0

0.0000–0.1120

Mantoux test with 2 TE (positive > 5 mm)

7 (18.9)

0.0917–0.3451

Sputum + biopsy specimen microscopy for MBT (positive)

0

0.0000–0.1120

The level of angiotensin converting enzyme (ACE)

14/34 (41.2)

0.2766–0.5241